NDC12 Readiness Planning Guide

The NDC12 Readiness Planning Guide is a comprehensive implementation guide for organizations preparing for the FDA's transition from the 10-digit National Drug Code (NDC) to the 12-digit National Drug Code (NDC12). The guide explains how to plan and manage an NDC12 implementation by defining project phases, planning assumptions, industry dependencies, governance structures, and implementation approaches needed to meet the FDA's March 7, 2033 compliance deadline.

Rather than summarizing the FDA Final Rule, this guide focuses on implementation planning. It introduces practical concepts such as Assessment, Working Groups, Steering Committees, Readiness Plans, Master Implementation Plans, Sequential Planning, Parallel Planning, Time-Boxed Planning, Internal Testing, External Testing, and management of cross-industry dependencies that affect successful NDC12 implementation.

Topics covered include:

• FDA Final Rule for the 12-digit National Drug Code (NDC12)

• Five phases of an NDC12 implementation project

• NDC12 Assessment and Readiness Planning

• Working Groups and Steering Committees

• Master Implementation Planning

• Sequential Planning, Parallel Planning, and Time-Boxed Planning

• Industry dependencies, standards, and trading partner readiness

• Internal and External Testing Strategies

• The free NDC12 Readiness Planning Tool

The guide is intended for pharmaceutical manufacturers, repackagers, distributors, pharmacies, healthcare providers, payers, software vendors, regulatory affairs professionals, healthcare IT leaders, program managers, and other organizations responsible for planning or implementing the transition to the FDA's 12-digit National Drug Code.